Ronald Blue Trust, Inc. Horizon Therapeutics Public LTD CO Transaction History

Ronald Blue Trust, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 18, 2024	BUY	$0.0 - $116.3 $0 - $4,884	42 New	42 $5,000
Q2 2023 Jul 14, 2023	SELL	$96.34 - $112.38 $9,634 - $11,238	-100 Reduced 90.91%	10 $1,000
Q1 2023 Apr 17, 2023	BUY	$107.32 - $113.5 $8,800 - $9,307	82 Added 292.86%	110 $13,000
Q4 2022 Jan 17, 2023	BUY	$62.39 - $113.8 $873 - $1,593	14 Added 100.0%	28 $2,000
Q2 2022 Aug 09, 2022	BUY	$79.4 - $116.36 $1,111 - $1,629	14 New	14 $1,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

Stay updated on Ronald Blue Trust, Inc. with notifications on news.